These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 26261678)
1. Endometrial tubal metaplasia in a young puerperal woman after breast cancer. Di Benedetto L; Giovanale V; Caserta D Int J Clin Exp Pathol; 2015; 8(6):7610-3. PubMed ID: 26261678 [TBL] [Abstract][Full Text] [Related]
2. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen. Lee M; Piao J; Jeon MJ Yonsei Med J; 2020 Apr; 61(4):317-322. PubMed ID: 32233174 [TBL] [Abstract][Full Text] [Related]
3. [Uterine abnormalities in non menopausal women who received tamoxifen for breast cancer adjuvant therapy]. d'Arailh AS; Michy T; Pioud R; Dravet F; Classe JM Gynecol Obstet Fertil; 2007 Dec; 35(12):1215-9. PubMed ID: 18035581 [TBL] [Abstract][Full Text] [Related]
4. Microwave endometrial ablation for endometrial protection in women with breast cancer on adjuvant tamoxifen. Zhu Y; Yang J J Obstet Gynaecol Res; 2013 Sep; 39(9):1411-4. PubMed ID: 23815697 [TBL] [Abstract][Full Text] [Related]
5. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy]. Hauth E; Libera H; Kimmig R; Forsting M Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840 [TBL] [Abstract][Full Text] [Related]
6. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Deligdisch L; Kalir T; Cohen CJ; de Latour M; Le Bouedec G; Penault-Llorca F Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800 [TBL] [Abstract][Full Text] [Related]
7. [Some specifics of tamoxifen's effect on the endometrium in menopausal cancer patients]. Ashtrafian LA; Antonova IB; Chazova NL; Motskobili TA; Babaeva NA; Al'ditskiĭ IA Vopr Onkol; 2005; 51(2):200-5. PubMed ID: 16223001 [TBL] [Abstract][Full Text] [Related]
8. Postmenopausal endometrial pathologies with tamoxifen treatment: comparison between hysteroscopic and hysterectomy findings. Cohen I; Azaria R; Aviram R; Bernheim J; Tepper R; Cordoba M; Beyth Y Gynecol Obstet Invest; 1999; 48(3):187-92. PubMed ID: 10545744 [TBL] [Abstract][Full Text] [Related]
9. Factors associated with endometrial pathology during tamoxifen therapy in women with breast cancer: a retrospective analysis of 821 biopsies. Jeon J; Kim SE; Lee DY; Choi D Breast Cancer Res Treat; 2020 Jan; 179(1):125-130. PubMed ID: 31541382 [TBL] [Abstract][Full Text] [Related]
10. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer. Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP Menopause; 2009; 16(2):293-300. PubMed ID: 19034048 [TBL] [Abstract][Full Text] [Related]
11. Tamoxifen-induced endometrial polyp. A case report and review of the literature. Nomikos IN; Elemenoglou J; Papatheophanis J Eur J Gynaecol Oncol; 1998; 19(5):476-8. PubMed ID: 9863916 [TBL] [Abstract][Full Text] [Related]
12. Hysteroscopically targeted biopsies compared with blind samplings in endometrial assessment of menopausal women taking tamoxifen for breast cancer. Garuti G; Cellani F; Colonnelli M; Garzia D; Gonfiantini C; Luerti M J Am Assoc Gynecol Laparosc; 2004 Feb; 11(1):62-7. PubMed ID: 15104834 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of endometrium during tamoxifen therapy of breast cancer]. Obrebowska A; Sibila-Owczarska A; Sajdak S Ginekol Pol; 2002 Nov; 73(11):1109-12. PubMed ID: 12722407 [TBL] [Abstract][Full Text] [Related]
14. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings. Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510 [TBL] [Abstract][Full Text] [Related]
15. Endometrial histologic changes in post-menopausal breast cancer patients using tamoxifen. Marchesoni D; Driul L; Fabiani G; Di Loreto C; Cataldi P; Mozzanega B Int J Gynaecol Obstet; 2001 Dec; 75(3):257-62. PubMed ID: 11728486 [TBL] [Abstract][Full Text] [Related]
16. [Benign endometrial lesions induced by tamoxifen]. De Muylder X J Gynecol Obstet Biol Reprod (Paris); 1999 Sep; 28(5):420-4. PubMed ID: 10566160 [TBL] [Abstract][Full Text] [Related]
17. Indication of hysteroscopy in tamoxifen treated breast cancer patients. Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527 [TBL] [Abstract][Full Text] [Related]
18. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586 [TBL] [Abstract][Full Text] [Related]
19. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy. Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR; Hum Reprod; 2005 Jan; 20(1):294-301. PubMed ID: 15513977 [TBL] [Abstract][Full Text] [Related]
20. Disaccordance between estimation of endometrial thickness as measured by transvaginal ultrasound compared with hysteroscopy and directed biopsy in breast cancer patients treated with tamoxifen. Liedman R; Lindahl B; Andolf E; Willen R; Ingvar C; Ranstam J Anticancer Res; 2000; 20(6C):4889-91. PubMed ID: 11205237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]